Compile Data Set for Download or QSAR
maximum 50k data
Found 45 Enz. Inhib. hit(s) with all data for entry = 1311
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316345( cis-N-tert-Butyl-2-[2-(3-chlorophenyl)-4-oxo-6-[3...)
Affinity DataKi: <1nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316327(US9617226, Example 8 | cis-2-[2-(3-Chlorophenyl)-4...)
Affinity DataKi: <1nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316365(US9617226, Example 46 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  1nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316361( cis-2-[2-(3-Chlorophenyl)-6-[3-[[(2S,6R)-2,6-dime...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316360(US9617226, Example 41 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316359(US9617226, Example 40 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316358(US9617226, Example 39 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316357(US9617226, Example 38 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316356( cis-2-[2-(3-Chlorophenyl)-6-[3-[ [(3S)-3-hydroxy-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316355(US9617226, Example 36 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316353(US9617226, Example 34 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316352( cis-2-[2-(3-Chlorophenyl)-6-[3-[[(3R)-3-hydroxy-1...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316333(US9617226, Example 14 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316350(US9617226, Example 31 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316337(US9617226, Example 18 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316338(US9617226, Example 19 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316322(US9617226, Example 2a | cis-2-[2-(3-chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316340( cis-2-[6-[3-(Azepan-1-ylmethyl)cyclobutyl]-2-(3-c...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316341(US9617226, Example 22 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316342( cis-2-[2-(3-Chlorophenyl)-6-[3-[(3-hydroxy-8-azab...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316329(US9617226, Example 10 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316344(US9617226, Example 25 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316328(US9617226, Example 11 | US9617226, Example 9 | cis...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316331(US9617226, Example 12 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316332(US9617226, Example 13 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316335(US9617226, Example 16 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316349(US9617226, Example 30 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316364( cis-2-[2-(3-Chlorophenyl)-4-oxo-6-[3-(1-piperidyl...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316363(US9617226, Example 44 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  5.5nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316362( cis-2-[2-(3-Chlorophenyl)-6-[3-[(2,6-dimethylmorp...)
Affinity DataKi:  55nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316354( cis-2-[2-(3-Chlorophenyl)-6-[3-[(3-methoxyazetidi...)
Affinity DataKi:  55nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316351(US9617226, Example 32 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  55nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316348(US9617226, Example 29 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  55nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316347( cis-2-[2-(3-Chlorophenyl)-4-oxo-6-[3-(1-piperidyl...)
Affinity DataKi:  55nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316346(US9617226, Example 27 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  55nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316343(US9617226, Example 24 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  55nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316339(US9617226, Example 20 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  55nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316336( cis-2-[2-(3-Chlorophenyl)-6-[3-(dimethylaminometh...)
Affinity DataKi:  55nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316334(US9617226, Example 15 | cis-2-[2-(3-Chlorophenyl)-...)
Affinity DataKi:  55nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316328(US9617226, Example 11 | US9617226, Example 9 | cis...)
Affinity DataKi:  55nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316326(Cis-2-[2-(3-Chlorophenyl)-6-[3-[(4-cyano-1-piperid...)
Affinity DataKi:  55nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316325(2-[2-(3-Chlorophenyl)-4-oxo-6-[2-(1-piperidylmethy...)
Affinity DataKi:  55nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316324(2-[2-(3-Chlorophenyl)-4-oxo-6-[2-[2-(1-piperidyl)e...)
Affinity DataKi:  55nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316323(US9617226, Example 2b | trans-2-[2-(3-chlorophenyl...)
Affinity DataKi:  55nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316321( 2-(2-(3-Chlorophenyl)-4-oxo-6-(3-(piperidin-1-ylm...)
Affinity DataKi:  55nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent